Worldwide Integration of Blockchain Technology
Mandamus R&D projects will enable better integration of Cryptocurrency Transactions into daily life, From tourist locations to the local daily mom and dad store. Pilot Programs will start in Puerto Rico and expand to every continent globally.
The Community Votes and we Research and Develop
Members of the crypto community will vote on different projects, and the platform will research and develop the project; after lunch, we will provide a fully open-source report on ways other crypto projects with other coins can integrate it into their blockchain and/or ecosystem.
Ten (10) Percent of All net revenue will be held in a reserve account in the United States of America. Reserve Account will be tied to the Mandamus Coin, and funds will be held in U.S. Dollars, Gold, and short-term U.S. government obligations. The Higher the value of the Mandamus Token and the more transactions made with the token, the higher the number of backed funds in the reserve account.
Mandamus Coin grows so does the charity contributions
Pay for treatment for infants with spinal muscular atrophy (SMA) type 1
Part of the generated revenue and growth of the Mandamus token will be used to pay for the treatment of infants with SMA. ZOLGENSMA is a prescription gene therapy used to treat children less than 2 years old with spinal muscular atrophy (SMA). ZOLGENSMA is given as a one-time infusion into a vein. Most of the Infants with SMA type 1 treated with Zolgensma survive after treatment. Zolgensma is one of the most expensive medicine in the world and with our support we can help infants if their insurance doesn't cover the full or partial treatment cost.
What is Spinal Muscular Atrophy Type 1?
Spinal muscular atrophy (SMA) is a genetic (inherited) neuromuscular disease that causes muscles to become weak and waste away. People with SMA lose a specific type of nerve cell in the spinal cord (called motor neurons) that control muscle movement. Without these motor neurons, muscles don’t receive nerve signals that make muscles move. The word atrophy is a medical term that means smaller. With SMA, certain muscles become smaller and weaker due to lack of use.
Type 1 (severe): About 60% of people with SMA have type 1 , also called Werdnig-Hoffman disease. Symptoms appear at birth or within an infant’s first six months of life. Infants with type 1 SMA have difficulty swallowing and sucking. They don’t meet typical milestones like holding up their heads or sitting. As muscles continue to weaken, children become more prone to respiratory infections and collapsed lungs(pneumothorax). Most children with type 1 SMA die before their second birthday.
Join our Waiting list!
We are currently developing the Platform. Fill out the form to get updates on our stages of development. You can still buy the Mandamus token via UNISwap and Tokpie Exchange
Support the platform and Donate ETH or any other ERC-20 Token to:
or donate via coinbase commerce